Bafna Pharmaceuticals: The Board of Directors in its Meeting held on November 11, 2026 inter-alia considered and approved the…
Bafna Pharmaceuticals (BAFNAPH) filed a disclosure titled "The Board of Directors in its Meeting held on November 11, 2026 inter-alia considered and approved the Unaudited Financial Results of the Company along with the". The company is valued at about…
What happened
Bafna Pharmaceuticals (BAFNAPH) filed a disclosure with the exchanges on 11 November 2026 at 04:46 PM titled "The Board of Directors in its Meeting held on November 11, 2026 inter-alia considered and approved the Unaudited Financial Results of the Company along with the".
From the filing: "We hereby inform you that the Board of Directors in its Meeting held on November 11, 2026 inter-alia considered and approved the Unaudited Financial Results of the Company along with the ...."
Company snapshot
Bafna Pharmaceuticals is a small-cap company, with a market value of about ₹1,141 crore.
The stock last traded at ₹482.3, against a 52-week range of ₹94.77–₹482.3 (0.0% above the high).
Before this filing the shares had moved +15.4% over the month and +65.9% over three months. Average daily turnover over the last 20 sessions was about ₹0.31 crore.
Promoters held 75.00% at the end of Q1 FY27. Foreign institutions owned 9.34% and domestic institutions 0.00%.
| Quarter | Revenue | Net profit | EPS (₹) |
|---|---|---|---|
| Q1 FY26 | 35 | 3.4 | 1.43 |
| Q2 FY26 | 35 | 3.1 | 1.32 |
| Q3 FY26 | 38 | 1.8 | 0.78 |
| Q4 FY26 | 42 | 2.7 | 1.16 |
| Q1 FY27 | 27 | 0.1 | 0.03 |
What history shows
This is not the company's first results disclosure: BCEIE has 2 earlier filings of this kind on record since May 2026.
Market-wide, 11,585 results filings with an impact score of 50 or more saw an average next-day move of −0.3%, with 43% rising.
Past reactions describe what happened before; they are not a forecast.
What to watch
- Management commentary, margins and order book or guidance in the investor presentation.
- 11 November 2026: Board meeting — Financial Results.
Source
Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.